摘要

Authors' objectives: This health technology assessment evaluates the effectiveness, safety, and cost-effectiveness of repetitive transcranial magnetic stimulation (rTMS) for people with treatment-resistant depression (TRD). It also evaluates the budget impact of publicly funding rTMS and the experiences, preferences, and values of people withTRD.